期刊文献+

大肠癌患者手术前后外周血淋巴细胞CD44的表达

Expression of peripheral blood CD44 in patients with colon cancer
下载PDF
导出
摘要 目的:研究大肠癌患者手术前后细胞表面黏附分子CD44在外周血淋巴细胞中的表达及临床意义。方法:根治术的大肠癌患者39例,男24例,女15例,年龄30岁-57岁,平均39岁。应用流式细胞免疫学方法检测外周血淋巴细胞中CD44的表达,并与正常对照(n=25)进行比较。结果:大肠癌患者外周血淋巴细胞中CD44的表达均明显高于正常对照(407.1±12.3VS321.7±15.1,P〈0.01),手术后2周(351.2±15.4)和12个月(345.1±18.2)表达降低,但仍高于对照(P〈0.05)。大肠癌中晚期CD44的表达明显高于早期(439.7±21.6 vs 393.2±17.5,P〈0.05),大肠癌有转移患者CD44表达均高于无转移(432.1±16.2vs 398.1±16.6,P〈0.01),但不同组织类型的大肠癌CD44表达无显著性差异(P〉0.05)。结论:大肠癌患者外周血淋巴细胞中CD44的表达水平明显高于正常对照,且手术后可以明显下降,其表达水平与大肠癌的进展情况及有无转移、预后有一定关系。 Objective:To investigate the expression of peripheral blood CD44 in colon cancer. Methods: Data of forty-nine patients ( male 24, female 15, age ranging from 30 to 57 ) with colon cancer undergoing gastrectomy were reviewed, and 25 normal donors served as controls. The expression of peripheral blood CIM4 detected by flow-cytometry. Results: The peripheral blood lymphocyte CIM4 contents in patients with colon cancer were significantly higher than those in normal controls (407.1±12.3 vs 321.7±15.1, P〈0.01 ), and CIM4 lower (P〈0.05 ) after operation in 2 weeks (351.2± 15.4) and 12 months (345.1±18.2). Distinctly statistic difference was showed between CIM4 in advanced stage and early stages (439.7 ±21.6 vs 393.2±17.5, P〈0.05) ; colon cancer with metastasis or distance metastasis showed higher expression of CD4 than that without metastasis or distance metastasis (432.1±16.2 vs 398.1±16.6, P〈0.01 ). No difference in CD4 contents was observed in different histopathological types in colon cancer. ( P〉0.05 ). Conclusion: The peripheral blood lymphocyte CD44 contents in colon cancer are significantly higher, and CD4 lower after operation. The CD4 expression in colon cancer might be an important means to differentiate benign from malignant renal tumor, and to detect invasive or metastasis and estimate prognosis of colon cancer.
出处 《现代肿瘤医学》 CAS 2006年第8期967-969,共3页 Journal of Modern Oncology
关键词 大肠癌 外周血 CD44 流式细胞免疫学 colon cancer peripheral blood CD44 flow-cytometry cellular immunology
  • 相关文献

参考文献2

二级参考文献26

  • 1Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Hanssmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. A new variant of glycoprotein CD44 confers metastasis potential to rat carcinoma cells. Cell 1991; 65: 13-24
  • 2Yamaguchi A, Goi T, Yu J, Hirono Y, Ishida M, Iida A, Kimura T, Takeuchi K, Katayama K, Hirose K. Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis. J Surg Oncol 2002; 79: 230-235
  • 3Hefler L, Tempfer C, Haeusler G, Kucera E, Mayerhofer K, Zeillinger R, Reinthaller A, Kain Z. Cytosol concentrations of CD44 isoforms in breast cancer tissue. Int J Cancer 1998; 79: 541-545
  • 4Stokes GN, Shelton JB Jr, Zahn CM, Kendall BS. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma. Gynecol Oncol 2002; 84: 58-61
  • 5Yang L, Xia JG, Zheng SZ, Chen GY. The radioimmunoimaging of 131I labeled CD44v6 monoclonal antibody in nude mice with metastatic focus of gastric cancer in vivo. Acta Nanjing Med Univ 2002; 22: 282-283
  • 6Zheng J, Deng YP, Lin C, Fu M, Xiao PG, Wu M. Arsenic trioxide induces apoptosis of HPV16 DNA -immortalized human cervical epithelial cells and selectively inhibits viral gene expression. Int J Cancer 1999; 82: 286-292
  • 7Goodison S, Yoshida K, Sugino T, Woodman A, Gorham H, Bolodeoku J, Kaufmann M, Tarin D. Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors. Cancer Res 1997; 57: 3140-3144
  • 8Schrewe H, Thompson J, Bona M, Hefta LJ, Maruya A, Hassauer M, Schively JE, von Kleist S, Zimmermann W. Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression. Mol Cell Biol 1990; 10: 2738-2748
  • 9Barbour AP, Reeder JA, Walsh MD, Fawcett J, Antalis TM, Gotley DC. Expression of the CD44v2-10 isoform confers a metastatic phenotype: Importance of the heparan sulfate attachment site CD44v3. Cancer Res 2003; 63: 887-892
  • 10Reeder JA, Gotley DC, Walsh MD, Fawcett J, Antalis TM. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Cancer Res 1998; 58: 3719-3726

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部